In a newly published study, researchers call for clinical trials of an FDA-approved heart medication.
A federally approved heart medication shows significant effectiveness in interfering with SARS-CoV-2 entry into the human cell host, according to a new study by a research team from Texas A&M University and The University of Texas Medical Branch (UTMB).
By Texas A&M University Research Communications and Public Relations – FEBRUARY 22, 2021
